Breast

Clairity founder Connie Lehman to become CEO
By AuntMinnie.com staff writers
Clairity founder Connie Lehman, MD, PhD, will serve as the company's CEO while Joe Kiani will chair its board of directors.
January 22, 2026
Lehman Connie Thumbnail
Is risk-based breast cancer screening more beneficial for patients?
By Amerigo Allegretto
Population risk-based breast cancer screening may led to “similar or greater benefits” than age-based screening, results showed.
January 20, 2026
Breast Cancer2 400
iSono launches point-of-care breast ultrasound system
By AuntMinnie.com staff writers
Multicenter study will include the wearable, portable 3D breast ultrasound system.
January 16, 2026
2022 05 03 Isono Health Thumbnail
MBI remains underused despite high performance
By Amerigo Allegretto
Molecular breast imaging (MBI) continues to be underused, with an overall decline in utilization between 2017 and 2022.
January 16, 2026
Breast Cancer
DBT's performance suffers when imaging extremely dense breasts
By Amerigo Allegretto
Digital breast tomosynthesis (DBT) has lower sensitivity when imaging extremely dense breasts compared with other density categories.
January 14, 2026
Breast Dbt Social
Breast MRI shows higher BPE levels in Black women
By Liz Carey
Studies suggest a positive association between increasing ordinal levels of background parenchymal enhancement (BPE) and breast cancer risk.
January 13, 2026
2026 01 13 Parenchymal Enhancement Minimal To Marked Thumbnail
Physicians make more reliable TikToks about breast cancer screening
By Amerigo Allegretto
While the overall quality of breast cancer screening info on TikTok varies, physician-created videos are more reliable.
January 9, 2026
Tik Tok Logo Screen
Lobular breast histology not strong predictor of SLNB positivity
By Amerigo Allegretto
Lobular histology is not a strong predictor of sentinel lymph node biopsy (SLNB) positivity in early-stage breast cancer cases.
January 7, 2026
Breast Imaging Computer Screen Thumbnail (1)
CEM is a reliable tool for evaluating screening recalls
By Amerigo Allegretto
Research shows that contrast-enhanced mammography (CEM) can accurately evaluate recalled screening mammograms.
January 5, 2026
Contrast Injector 400 (1)
Most women positive toward receiving breast cancer risk communication
By Amerigo Allegretto
Most women perceive easing worry as an advantage of learning their breast cancer risk and screening plan.
January 2, 2026
Breast Screening Mammo 400
Age affects abnormal interpretation rates for combined DBT, WBUS
By Amerigo Allegretto
Abnormal interpretation rates vary with age when combining digital breast tomosynthesis (DBT) with whole-breast ultrasound (WBUS).
December 30, 2025
Ultrasound Diagnostic 400
Brain imaging, billing, radiation exposure top 2025's most-read list
By Liz Carey
Snapshots we've curated in this roundup make it easy for you to review what AuntMinnie's members read the most in 2025.
December 22, 2025
Top 10 Paint
Page 1 of 578
Next Page